Hairy-cell leukaemia: Biology and management

British Journal of Haematology

Volumn 106, Issue 1, 1999, Pages 2-8

  Pettitt, A R ^a   Zuzel, M ^a   Cawley, J C ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Hairy cell leukaemia; Interferon ; Nucleosides

Indexed keywords

ADENOSINE DERIVATIVE; ALPHA INTERFERON; CLADRIBINE; FLUDARABINE; PENTOSTATIN;

ANTINEOPLASTIC ACTIVITY; BONE MARROW SUPPRESSION; DRUG EFFICACY; HAIRY CELL LEUKEMIA; HUMAN; PRIORITY JOURNAL; RELAPSE; REVIEW;

HUMANS; INTERFERON-ALPHA; LEUKEMIA, HAIRY CELL; NUCLEOSIDES; RECURRENCE;

EID: 0037808153     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01500.x     Document Type: Review

References (71)

1. al-Katib, A., Wang, C.Y., McKenzie, S., Clarkson, B.D. & Koziner, B. (1992) Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in-vitro. American Journal of Hematology, 40, 264-269.
2. Anderson, K.C., Boyd, A.W., Fisher, D.C., Leslie, D., Schossman, S.F. & Nadler, L.M. (1985) Hairy cell leukemia: a tumor of pre-plasma cells. Blood, 65, 620-629.
3. Blasinska-Morawiec, M., Robak, T., Krykowski, E., Hellman, A. & Urbanska-Rys, H. (1997) Hairy cell leukaemia-variant treated with 2′-chlorodeoxyadenosine: a report of three cases. Leukemia and Lymphoma, 25, 381-385.
4. Bolam, S., Orchard, J. & Oscier, D. (1997) Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes. British Journal of Haematology, 99, 158-161.
5. Bryson, H.M. & Sorkin, E.M. (1993) Cladribine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in haematological malignancies. Drugs, 46, 872-894.
6. Burke, J.S., Byrne, G.E. & Rappaport, H. (1974) Hairy cell leukemia (leukemic reticuloendotheliosis): a clinical pathologic study of 21 patients. Cancer, 33, 2267-2274.
7. Burns, G.F., Cawley, J.C., Worman, C.P., Karpas, A., Barker, C.R., Goldstone, A.H. & Hayhoe, P.G.J. (1978) Multiple heavy chain isotopes on the surface of the cells of hairy cell leukemia. Blood, 52, 1132-1136.
8. Burthem, J., Baker, P.K., Hunt, J.A. & Cawley, J.C. (1994) Hairy cell interactions with extracellular matrix: expression of specific integrin receptors and their role in the cell's response to specific adhesive proteins. Blood, 84, 873-882.
9. Burthem, J. & Cawley, J.C. (1994) The bone marrow fibrosis of hairy-cell leukaemia is caused by the synthesis and assembly of a libronectin matrix by the hairy cells. Blood, 83, 497-504.
10. Burthem, J. & Cawley, J.C. (1996) Hairy Cell Leukaemia. Springer, London.
11. Burthem, J., Zuzel, M. & Cawley, J.C. (1997) What is the nature of the hairy cell and why should we be interested? British Journal of Haematology, 97, 511-514.
12. Caligaris-Cappio, F., Pizzolo, G., Chilosi, M., Bergui, L., Semenzato, G., Tesio, L., Morittu, L., Malavasi, F., Gobbi, M., Schwarting, R., Campana, D. & Janossy, G. (1985) Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia. Blood, 66, 1035-1042.
13. Caligaris-Cappio, F.G., Bergui, L., Corbascio, G., Tousco, F. & Marchisio, P.C. (1986) Cytoskeletal organisation is aberrantly rearranged in the cells of B chronic lymphocytic leukemia. Blood, 67, 233-239.
14. Catovsky, D., Golomb, H.M. & Golde, D.W. (1987) General commentary on the Second International Workshop. Leukemia, 1, 407-408.
15. Catovsky, D., Matutes, E., Talavera, J.G., O'Connor, N.T.J., Johnson, S.A.N., Emmett, E., Corbett, L. & Swansbury, J. (1994) Long-term results with 2′-deoxycoformycin in hairy cell leukemia. Leukemia and Lymphoma, 14, (Suppl.), 109-113.
16. Cordingley, F.T., Bianchi, A., Hoffbrand, A.V., Reittie, J.E., Heslop, H.E., Vyakarnamm, A., Turner, M., Meager, A. & Brenner, M.K. (1988) Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet, 1, 969-971.
17. de Totero, D., Carbone, A., Tazzari, P.L., Raspadori, D., Ventura, A., Reato, G., Lauria, F. & Foa, R. (1994) Expression of the IL-2 receptor α, β and γ chains in hairy cell leukaemia. Leukemia and Lymphoma, 14, (Suppl. 1), 27-32.
18. Genot, E.M., Meier, K.E., Licciardi, K.A., Ahn, N.G., Uittenbogaart, C.H., Weitzerbin, J., Clark, E.A. & Valentine, M.A. (1993) Phosphorylation of CD20 in cells from a hairy cell leukaemia cell line: evidence for involvement of calcium/calmodulin-dependent protein kinase II. Journal of Immunology, 151, 71-82.
19. Glaspy, J.A., Baldwin, G.C., Robertson, P.A., Souza, L., Vincent, M., Ambersley, J. & Golde, D.W. (1988) Therapy for neutropenia in hairy cell leukemia with recombinant granulocyte colony-stimulating factor. Annals of Internal Medicine, 109, 789-795.
20. Golomb, H.M., Jacobs, A., Fefer, A., Ozer, H., Thompson, J., Portlock, C., Ratain, M., Golde, D., Vardiman, J., Burke, J.S., Brady, J., Bonnem, E. & Spiegel, R. (1986) Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients. Journal of Oncology, 4, 900-905.
21. Gordon, J. & Smith, J.L. (1978) Free immunoglobulin light chain synthesis by neoplastic cells in leukaemic reticuloendotheliosis. Clinical and Experimental Immunology, 31, 244-250.
22. Habermann, T.M., Andersen, J.W., Cassileth, P.A., Bennett, J.M. & Oken, M.M. (1992) Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia. British Journal of Haematology 80, 466-471.
23. Haglund, U., Julinsson, G., Stellan, B. & Gahrton, G. (1994) Hairy cell leukemia is characterised by clonal chromosome abnormalities clustered to specific regions. Blood, 83, 2637-2645.
24. Hakimian, D., Tallman, M.S., Kiley, C. & Peterson, L. (1993) Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chloro-deoxyadenosine for hairy cell leukemia. Blood, 82, 1798-1802.
25. Hansen, D.A., Robbins, B.A., Bylund, D.J., Piro, L.D., Saven, A. & Ellison, D.J. (1994) Identification of monoclonal immunoglobulins and quantitative immunoglobulin abnormalities in hairy cell leukemia and chronic lymphocytic leukemia. American Journal of Clinical Pathology, 102, 580-585.
26. Ho, A.D., Thaler, J., Mandelli, F., Lauria, F., Zittoun, R., Willemze, R., McVic, G., Marmont, A.M., Prummer, O. & Strychmans, L. (1989) Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organisation for Research and Treatment of Cancer Leukemia Cooperative Group. Journal of Clinical Oncology, 7, 1533-1538.
27. Hoffman, M.A., Janson, D., Rose, E., & Rai, K.R. (1997) Treatment of hairy-cell leukemia with cladribine: response, toxicity and long-term follow-up. Journal of Clinical Oncology, 15, 1138-1142.
28. Jacobs, R.H., Vokes, E.E. & Golomb, H.M. (1985) Second malignancies in hairy cell leukemia. Cancer, 56, 1462-1467.
29. Juliusson, G., Lenkei, R. & Liliemark, J. (1994) Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine. Blood, 83, 3672-3681.
30. Kampmeier, P., Spielberger, R., Dickstein, J., Mick, R., Golomb, H. & Vardiman, J.W. (1994) Increased incidence of second neoplasms in patients treated with interferon-α-2b for hairy cell leukemia: a clinicopathological assessment. Blood, 83, 2931-2938.
31. Kantarjian, H.M., Schachner, J. & Keating, M.J. (1991) Fludarabine therapy in hairy cell leukemia. Cancer, 67, 1291-1293.
32. Kluin-Nelemans, H.C., Beverstock, G.C., Mollevanger, P., Wessels, H.W., Hoogendoorn, E., Willemze, R. & Falkenburg, J.H. (1994) Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood, 84, 3134-3141.
33. Kluin-Nelemans, H.C., Krouwels, M.M., Jansen, J.H., Dijkstra, K., van-Tol, M.J., den-Otterlander, G.J., Dreef, E.J. & Kluin, P.M. (1990) Hairy cell leukemia preferentially expresses the IgG3-subclass. Blood, 75, 972-975.
34. Kluin-Nelemans, J.C., Kester, M.G., Melenhorst, J.J., Landegent, J.E., van de Corput, L., Willemze, R. & Falkenburg, J.H. (1996) Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood, 87, 3795-3802.
35. Kraut, E.H., Bouroncle, B.A. & Grever, M.R. (1989) Pentostatin in the treatment of advanced hairy cell leukemia. Journal of Clinical Oncology, 7, 168-172.
36. Kraut, E.H., Grever, M.R. & Bouroncle, B.A. (1994) Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood, 84, 4061-4063.
37. Kurzrock, R., Strom, S.S., Estey, E., O'Brien, S., Keating, M.J., Jiang, H., Adams, T. & Talpaz, M. (1997) Second cancer risk in hairy cell leukemia: analysis of 350 patients. Journal of Clinical Oncology, 15, 1803-1810.
38. Lauria, F., Bocchia, M., Marotta, G., Raspadori, D., Zinzani, P.L. & Rondelli, D. (1997) Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications. Blood, 89, 1838-1839.
39. Lorber, C., Willfort, A., Ohler, L., Jager, U., Schwarzinger, L., Lechner, K. & Geissler, K. (1993) Granulocyte colony-stimulating factor (rh G-CSF) as an adjunct to interferon alpha therapy of neutropenic patients with hairy cell leukemia. Annals of Hematology, 67, 13-16.
40. Lower, E.E., Franco, R.S. & Martelo, O.J. (1992) Increased tyrosine protein kinase activity in hairy cell and monocytic leukemias. American Journal of the Medical Sciences, 303, 387-391.
41. Lynch, S.A., Brugge, J.S., Fromowitz, F., Glantz, L., Wang, P., Caruso, R. & Viola, M.V. (1993) Increased expression of the src protooncogene in hairy cell leukemia and a sub-group of B-cell lymphomas. Leukemia, 7, 1416-1422.
42. Maloum, L., Magnac, C., Azgui, Z., Cau, C., Charlotte, F., Binet, J.L., Merle-Beral, H. & Dighiero, G., (1998) VH gene expression in hairy cell leukaemia. British Journal of Haematology, 101, 171-178.
43. Matutes, E., Mecus, P., McLennan, K. & Catovsky, D. (1997) The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long-term follow-up study. British Journal of Haematology, 98, 375-383.
44. Matutes, E., Morilla, R., Owusu-Ankomah, K., Houliham, A., Meeus, P. & Catovsky, D. (1994) The immunophenotype of hairy cell leukemia (HCL): proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leukemia and Lymphoma, 14, (Suppl. 1), 57-62.
45. Mercieca, J., Matutes, E., Emmett, E., Coles, H. & Catovsky, D. (1996) 2-chlorodeoxyadenosine in the treatment of hairy cell leukaemia: differences in responses in patients with and without abdominal lymphadenopathy. British Journal of Haematology, 93, 409-411.
46. Mercieca, J., Matutes, E., Moskovic, E., MacLennan, K., Matthey, F., Costello, C., Behrens, J., Basu, S., Roath, S., Fairhead, S., Flandrin, G., Brizard, A. & Catovsky, D. (1992) Massive abdominal lymphadenopathy. British Journal of Haematology, 82, 547-554.
47. Micklem, K.J., Dong, Y., Willia, A., Pulford, K.A., Visser, L., Durkop, H., Poppema, S., Stein, H. & Mason, D.Y. (1991) HML-1 antigen on mucosa-associated T cells, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit. American Journal of Pathology, 139, 1297-1301.
48. Mulligan, S.P., Matutes, E., Dearden, C. & Catovsky, D. (1991) Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. British Journal of Haematology, 78, 206-209.
49. Nanba, K., Soban, E.J., Bowling, M.C. & Berad, C.W. (1977) Splenic pseudosinuses and hepatic angiomatous lesions: distinctive features of hairy cell leukemia. American Journal of Clinical Pathology, 67, 415-426.
50. Pawson, R., A'ttern, R. & Catovsky, D. (1996) Second malignancy in hairy cell leukaemia: no evidence of increased incidence after treatment with interferon alpha. Leukemia and Lymphoma, 22. 103-106.
51. Piro, L.D., Carrera, C.J., Carson, D.A. & Beutler, E. (1990) Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. New England Journal of Medicine, 322, 1117-1121.
52. Piro, L.D., Ellison, D.J. & Saven, J. (1994) The Scripps clinical experience with 2-chloro-deoxyadenosine in the treatment of hairy cell leukemia. Leukemia and Lymphoma, 14, (Suppl. 1), 121-125.
53. Posnett, D.N., Duggan, A. & McGrath, H. (1990) Hairy-cell leukemia-associated antigen (HC2) is an activation antigen of several hemopoietic cell lineages, inducible on monocytes by IFN-gamma. Journal of Immunology, 144, 929-933.
54. Quesada, J.R., Reubin, J., Manning, J.T., Hersh, E.M. & Gutterman, J.U. (1984) Alpha-interferon for induction of remission in hairy cell leukemia. New England Journal of Medicine, 310, 15-18.
55. Sainati, L., Matutes, E., Mulligan, S., de Oliveira, M.P., Rani, S., Lampert, I.A. & Catovsky, D. (1990) A variant form of hairy cell leukemia resistant to α-interferon: clinical and phenotypic characteristics of 17 patients. Blood, 76, 157-162.
56. Saven, A., Burtan, C., Koztol, J.A. & Piro, L.D. (1998) Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood, 92, 1918-1926.
57. Seshadri, R.S., Brown, E.J. & Zipursky, A. (1976) Leukemic reticuloendotheliosis: a failure of monocyte production. New England Journal of Medicine, 295, 181-184.
58. + lymphocyte counts in patients with hairy cell leukemia. Blood, 83, 2906-2911.
59. Smalley, R.V., Anderson, S.A., Tuttle, R.L., Connors, J., Thurmond, L.M., Huang, A., Castle, K., Magers, C. & Whisnant, J.K. (1991) A randomised comparison of two doses of human lymphoblastoid interferon-α in hairy cell leukemia. Blood, 78, 3133-3141.
60. Smalley, R.V., Connors, J., Tuttle, R.L., Anderson, S., Robinson, W. & Whisnant, J.K. (1992) Splenectomy vs alpha interferon: a randomised study in patients with previously untreated hairy cell leukemia. American Journal of Heamatology, 41, 13-18.
61. Spielberger, R.T., Mick, R., Ratain, M.J. & Golomb, H.M. (1994) Interferon treatment for hairy cell leukemia: an update on a cohort of 69 patients treated from 1983 to 1986. Leukemia and Lymphoma, 14, (Suppl. 1), 89-93.
62. Tallman, M.S., Hakimian, D., Rademaker, A.W., Zanzig, C., Wollins, E., Rose, E. & Peterson, L.C. (1996) Relapse of hairy cell leukemia after 2-chloro-deoxyadenosine: long-term follow-up of the North Western University experience. Blood, 88, 1954-1964.
63. Trentin, L., Zambello, R., Saucctta, R., Facco, M., Cerutti, A., Perin, A., Siviero, M., Basso, U., Bortolin, M., Adami, F., Agostini, C. & Semenzato, G. (1997) B lymphocytes from patients with chronic lymphoproliterative disorders are equipped with different costimulating molecules. Cancer Research, 57, 4940-4947.
64. Troussard, X., Valensi, F., Duchayne, E., Garand, R., Felman, P., Tulliez, M., Henry-Amar, M., Bryon, P.A. & Flandrin, G. (1996) Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. British Journal of Haematology, 93, 731-736.
65. Urba, W.J., Baseler, M.W., Kopp, W.C., Steis, R.G., Clark, J.W., Smith, J.W., Coggin, D.L., & Longo, D.L. (1989) Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia. Blood, 73, 38-46.
66. Vincent, A.M., Burthem, J., Brew, R. & Cawley, J.C. (1996) Endothelial Interactions of hairy cells: the importance of α4β1 in the unusual tissue distribution of the disorder. Blood, 88, 3945-3952.
67. Virchis, A. & Mehta, A. (1998) Splenic lymphoma with villous lymphocytes (SLVL) responding to 2′-chlorodeoxyadenosine (2-CdA). (Letter). British Journal of Haematology, 100, 609.
68. Wagner, S.D., Martinelli, V. & Luzzatto, L. (1994) Similar patterns of V kappa gene usage but different degrees of somatic mutation in hairy cell leukemia, Waldenstrom's macroglobulinemia, and myeloma. Blood, 83, 3647-3653.
69. Werfel, T., Koch, G. & Gotze, O. (1989) Human complement fragment C5a increases the expression of CD11b, CD11c, CD16, CD18, CD45, and other non-lineage antigens on myeloid cells. Leucocyte Typing IV. White Cell Differentiation Antigens (ed. by W. Knapp, B. Dorkin, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein and A. E. G. K. von dem Borne), pp. 563-564. Oxford University Press.
70. Wheaton, S., Tallman, M.S., Hakimian, D. & Petersen, L. (1996) Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Blood, 87, 1556-1560.
71. Wu, X., Merup, M., Juliusson, G., Jansson, M., Stellan, B., Grander, D., Zabarovsky, E., Liu, Y., Spasokoukotskaja, T., Gahrton, G. & Einhorn, S. (1997) Characterisation of a hairy cell leukemia-associated 5q13.3 inversion breakpoint. Genes, Chromosomes and Cancer, 20, 337-346.